Catalyst Wire Dossier Catalyst Wire Dossier

APLENZIN

BUPROPION HYDROBROMIDE · Bausch Health US, LLC
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for APLENZIN, covering 2008-04-23 to 2025-11-05. Get the full timeline:

Most recent: FDA Approved: APLENZIN — Supplemental Application (Bausch Health US, LLC)

See pricing